Literature DB >> 9420607

Spatial and temporal expression of fibril-forming minor collagen genes (types V and XI) during fracture healing.

M Yamazaki1, R J Majeska, H Yoshioka, H Moriya, T A Einhorn.   

Abstract

Skeletal development involves the coordinated participation of several types of collagen, including both major and minor fibrillar collagens. Although much is known about the major fibrillar collagens, such as types I and II, less is known about the minor fibrillar collagens, and their role in the repair and regeneration of bone has not been extensively studied. To clarify the role of minor fibrillar collagens in fracture repair, we examined the spatial and temporal expression of mRNAs for pro-alpha 2(V) collagen and pro-alpha 1(XI) collagen in healing fractures in the rat by in situ hybridization and compared their patterns of expression with those of mRNAs for pro-alpha 1(I) collagen, pro-alpha 1(II) collagen, and osteocalcin. A strong signal for pro-alpha 2(V) was detected in the periosteal osteoprogenitor cells, whereas osteocalcin mRNA was strongly expressed only in the deep layers of the hard callus. The distribution of the pro-alpha 2(V) signal was correlated with that of pro-alpha 1(I) but was mutually exclusive of that of pro-alpha 1(II). The expression of pro-alpha 1(XI) mRNA was synchronously regulated with that of pro-alpha 1(II) during chondrogenesis in the soft callus. In the hard callus, pro-alpha 1(XI) signal was found in osteoblastic cells at the site of intramembranous and endochondral ossification. These cells simultaneously expressed pro-alpha 2(V), although they were negative for pro-alpha 1(II). These findings suggest that the alpha 2(V) collagen chain participates in the formation of the noncartilaginous fibrillar network in the hard callus and preferentially contributes to the initial stage of the intramembranous bone formation. Recent reports have revealed that type-XI collagen, which had been classified as a cartilage-type collagen, is not necessarily specific for cartilage. The present results advanced this recognition and demonstrated a coexpression of alpha 1(XI) mRNA and alpha 2(V) mRNA in the noncartilaginous tissues in the fracture callus; this suggests the presence of tissue-specific and stage-specific heterotrimers consisting of alpha 1(XI) and alpha 2(V) collagen chains and the association of such hybrid trimers with the major fibrillar collagens in the process of fracture healing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9420607     DOI: 10.1002/jor.1100150519

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  5 in total

1.  Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue.

Authors:  Luis Cardoso; Brad C Herman; Olivier Verborgt; Damien Laudier; Robert J Majeska; Mitchell B Schaffler
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

2.  Bone regeneration with osteogenically enhanced mesenchymal stem cells and their extracellular matrix proteins.

Authors:  Bret H Clough; Matthew R McCarley; Ulf Krause; Suzanne Zeitouni; Jeremiah J Froese; Eoin P McNeill; Christopher D Chaput; H Wayne Sampson; Carl A Gregory
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

3.  Osteocyte apoptosis is required for production of osteoclastogenic signals following bone fatigue in vivo.

Authors:  Oran D Kennedy; Damien M Laudier; Robert J Majeska; Hui B Sun; Mitchell B Schaffler
Journal:  Bone       Date:  2014-04-04       Impact factor: 4.398

4.  Mimicking the Organic and Inorganic Composition of Anabolic Bone Enhances Human Mesenchymal Stem Cell Osteoinduction and Scaffold Mechanical Properties.

Authors:  Eli Mondragón; Mitzy Cowdin; Francesca Taraballi; Silvia Minardi; Ennio Tasciotti; Carl A Gregory; Roland Kaunas
Journal:  Front Bioeng Biotechnol       Date:  2020-07-03

5.  Col11a1 Regulates Bone Microarchitecture during Embryonic Development.

Authors:  Anthony Hafez; Ryan Squires; Amber Pedracini; Alark Joshi; Robert E Seegmiller; Julia Thom Oxford
Journal:  J Dev Biol       Date:  2015-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.